Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apyx Medical Corp Director's Dealing 2014

Sep 15, 2014

34303_dirs_2014-09-15_cb6397a7-2d05-4f4d-8dde-2effd7372c9e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOVIE MEDICAL CORP (BVX)
CIK: 0000719135
Period of Report: 2014-07-17

Reporting Person: Sheffield Ian (Director)
Reporting Person: GREAT POINT PARTNERS LLC (Director by deputization)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-17 Stock Option (Option to Buy) $3.81 A 12000 Acquired 2014-07-17 Common Stock (12000) Direct

Footnotes

F1: (1) Reporting person was granted a stock option to vest and be exercisable over 3 years at the rate of 33.33% of the option on the anniversary date of each succeeding year and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

F2: (2) The amounts shown represent the beneficial ownership of the issuer's securities by funds and certain managed accounts managed by Great Point Partners LLC (the "GPP Investors"), which may be deemed attributable to Mr. Sheffield. Mr. Sheffield serves as a director of the issuer as a representative of Great Point Partners LLC acting on behalf of the GPP Investors, and accordingly Great Point Partners LLC and the GPP Investors may be deemed to be a director by deputization. Great Point Partners, LLC and Mr. Sheffield each disclaim beneficial ownership of the shares except to the extent of his pecuniary interest therein.